| Literature DB >> 20858264 |
Hualing Li1,2,3, Changhong Ren2, Jinping Shi2, Xingyi Hang2, Feilong Zhang2, Yan Gao2, Yonghong Wu2, Langlai Xu1, Changsheng Chen4, Chenggang Zhang2.
Abstract
BACKGROUND: The nematode Caenorhabditis elegans is both sensitive and tolerant to hypoxic stress, particularly when the evolutionarily conserved hypoxia response pathway HIF-1/EGL-9/VHL is involved. Hypoxia-induced changes in the expression of a number of genes have been analyzed using whole genome microarrays in C. elegans, but the changes at the protein level in response to hypoxic stress still remain unclear.Entities:
Year: 2010 PMID: 20858264 PMCID: PMC2954870 DOI: 10.1186/1477-5956-8-49
Source DB: PubMed Journal: Proteome Sci ISSN: 1477-5956 Impact factor: 2.480
Figure 1DIGE maps of the . In GEL1 (top panel), the control lysate was labeled with Cy3 (green), and the lysate from 4 h hypoxia group was labeled with Cy5 (red). In GEL2 (bottom panel), reverse labeling was used so that the control was labeled with Cy5 (red) and the hypoxia group was labeled with Cy3 (green). For normalization in both gels, a mixture containing equal parts of the control and hypoxia groups was labeled with Cy2 (blue). The three Cy-dye labeled samples were co-separated on one gel, and the merged gel was created by the overlay of the three images. In total, 1,231 spots were matched from each of the fluorescent gels.
Figure 2The 2D-DIGE protein map. The number and positions of 23 selected spots (ratiohypoxia/control ≥ 1.5 for upregulated spots and ≤ -1.5 for downregulated spots, P < 0.05) labeled from 1 to 23 within the brackets for identification by MALDI-TOF/TOF-MS are shown. (A) control; (B) 4 h hypoxia. A total of 19 proteins were successfully identified.
List of differently expressed proteins in C. elegans wild type strain N2 with hypoxia treatment for 4 h
| Spot No. | Protein name | Score | Accession number | Theoretical mass (Da) | Theoretical | |
|---|---|---|---|---|---|---|
| 1 | Isoform a of tropomyosin isoforms a/b/d/f. lev-11 | 94 | Q22866-1 | 32984 | 4.66 | 0.037 |
| 2 | Protein F27D4.5, confirmed by transcript evidence.tag-173 | 177 | Q93619 | 40027 | 6.22 | 0.028 |
| 3 | Isoform a of probable arginine kinase. F46H5.3 | 152 | Q10454-1 | 44140 | 6.84 | 0.002 |
| 5 | Myosin regulatory light chain 1. mlc-1 | 496 | P19625 | 18605 | 5.06 | 0.004 |
| 6 | Fatty-acid and retinol-binding protein 1.far-1 | 528 | P34382 | 20097 | 6.98 | 0.031 |
| 7 | Actin protein 4, isoform c. act-4 | 530 | Q6A8K1 | 40400 | 5.56 | 0.021 |
| 8 | ATP synthase subunit beta, mitochondrial. atp-2 | 401 | P46561 | 57491 | 5.52 | 0.045 |
| 10 | Protein C06H2.1, confirmed by transcript evidence.atp-5 | 245 | Q17763 | 21784 | 6.67 | 0.042 |
| 11 | Vacuolar h Atpase protein 8.vha-8 | 153 | Q95X44 | 25570 | 6.78 | 0.048 |
| 12 | Protein ZK593.9, partially confirmed by transcript evidence | 66 | Q23538 | 595560 | 9.07 | 0.032 |
| 13 | Isoform b of probable arginine kinase. F46H5.3 | 83 | Q10454-2 | 39966 | 6.17 | 0.017 |
| 14 | Isoform a of muscle M-line assembly protein. unc-89 | 60 | O01761-2 | 731233 | 5.35 | 0.001 |
| 15 | 60S ribosomal protein L7. rpl-7 | 80 | O01802 | 28114 | 10.16 | 0.022 |
| 16 | 60S ribosomal protein L8. rpl-8 | 72 | Q9XVF7 | 28186 | 11.07 | 0.040 |
| 17 | Myosin regulatory light chain 2. mlc-2 | 493 | P19626 | 18591 | 5.06 | 0.034 |
| 18 | 40S ribosomal protein S8. rps-8 | 133 | P48156 | 23736 | 10.56 | 0.027 |
| 19 | Heat shock 70 kDa protein A. hsp-1 | 95 | P09446 | 69680 | 5.44 | 0.034 |
| 21 | Protein Y54E5A.5, confirmed by transcript evidence | 152 | Q9XWK2 | 17426 | 5.24 | 0.030 |
| 23 | 60S ribosomal protein L21. rpl-21 | 232 | P34334 | 18299 | 11.15 | 0.027 |
Figure 3Validation of the upregulation of the tropomyosin (32.9 kDa) protein in wild type N2 after 4 h hypoxia treatment. (A) Western blot analysis showing the upregulation of tropomyosin protein in wild type N2 after 4 h hypoxia treatment compared with the control. The protein α-tubulin (56.3 kDa) was used as an internal control. (B) Image analysis showing that the expression of tropomyosin (LEV-11) is significantly upregulated at 4 h hypoxia compared with the control (P = 0.0069). The expression pattern of LEV-11 was consistent with the quantitative proteomic results.
Figure 4Death rate of the . The death rate of the wild type N2 strain and lev-11(x12) mutant gradually increased as the time under hypoxic conditions increased. The daf-2 mutants were highly resistant to hypoxia, whereas the daf-16 mutants were highly sensitive to hypoxia. The death rate was significantly different when the wild type animals (8.85% ± 3.50, 26.44% ± 7.96) were compared with the lev-11 (x12) strain (27.64% ± 6.30, 64.06% ± 12.00) after 12 h and 14 h of hypoxia treatment, respectively (P = 0.0183, P = 0.0401). After 12 h of hypoxia, the death rate of the lev-11 (x12) strain was higher than that of the daf-16 mutant. The results are displayed as means ± standard deviation, n > 3, *: P < 0.05.
Gene ontology analysis of differently expressed proteins identified by MALDI-TOF/TOF MS
| GO ID | GO term | Number of proteins | Fold enrichment | |
|---|---|---|---|---|
| GO:0002119 | larval development | 11 (lev-11, rpl-8, rps-8, rpl-21, act-4, mlc-2, rpl-7, hsp-1, atp-2, atp-5, mlc-1) | 3.71 | 5.60E-05 |
| GO:0002164 | larval development | 11 (lev-11, rpl-8, rps-8, rpl-21, act-4, mlc-2, rpl-7, hsp-1, atp-2, atp-5, mlc-1) | 3.71 | 5.67E-05 |
| GO:0015986 | ATP synthesis coupled proton transport | 3 (vha-8, atp-2, atp-5) | 31.33 | 3.50E-03 |
| GO:0046034 | ATP metabolic process | 3 (vha-8, atp-2, atp-5) | 29.37 | 3.98E-03 |
| GO:0006818 | hydrogen transport | 3 (vha-8, atp-2, atp-5) | 23.49 | 6.15E-03 |
| GO:0015992 | proton transport | 3 (vha-8, atp-2, atp-5) | 23.49 | 6.15E-03 |
| GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances | 3 (vha-8, atp-2, atp-5) | 13.50 | 1.68E-02 |
| GO:0015399 | primary active transmembrane transporter activity | 3 (vha-8, atp-2, atp-5) | 13.28 | 1.73E-02 |
| GO:0051188 | cofactor biosynthetic process | 3 (vha-8, atp-2, atp-5) | 12.59 | 2.04E-02 |
| GO:0030554 | adenyl nucleotide binding | 6 (unc-89, act-4, hsp-1, atp-2, atp-5, ZK593.9) | 3.07 | 2.22E-02 |
| GO:0006732 | coenzyme metabolic process | 3 (vha-8, atp-2, atp-5) | 11.37 | 2.46E-02 |
| GO:0009165 | nucleotide biosynthetic process | 3 (vha-8, atp-2, atp-5) | 11.37 | 2.46E-02 |
| GO:0032555 | purine ribonucleotide binding | 6 (unc-89¬, act-4, hsp-1, atp-2, atp-5, ZK593.9) | 2.79 | 3.26E-02 |
| GO:0045927 | positive regulation of growth | 7 (far-1, mlc-1, atp-2, atp-5, rpl-7, rpl-8, tag-173) | 2.45 | 3.71E-02 |
| GO:0055086 | nucleobase, nucleoside and nucleotide metabolic process | 3 (vha-8, atp-2, atp-5) | 8.49 | 4.21E-02 |
| GO:0006796 | phosphate metabolic process | 5 (unc-89,ZK593.9, vha-8, atp-2, atp-5) | 3.31 | 4.61E-02 |